Operating across Poland's investment fund market, Generali Investments Towarzystwo Funduszy Inwestycyjnych runs SICAV and open-end funds targeting fixed income, equity and balanced mandates for retail and institutional clients. The firm leverages parent-group distribution and investment research to scale asset-gathering, emphasizes multi-asset allocation and risk-controlled strategies, and competes with domestic and international fund houses on fees and product innovation.
Operating across Poland's investment fund market, Generali Investments Towarzystwo Funduszy Inwestycyjnych runs SICAV and open-end funds targeting fixed income, equity and balanced mandates for retail and institutional clients. The firm leverages parent-group distribution and investment research to scale asset-gathering, emphasizes multi-asset allocation and risk-controlled strategies, and competes with domestic and international fund houses on fees and product innovation.
Positioned as a multi‑asset fund manager in Poland, it emphasizes scalable retail and institutional distribution through its parent group while deploying a diversified, risk‑budgeted approach across fixed income, equities and balanced mandates. Capital allocation favors liability‑aware bond strategies, active equity selection and opportunistic credit within clearly defined liquidity and drawdown limits. Product strategy blends active and cost‑efficient passive solutions, prioritizes fee competitiveness, governance, centralized research and pragmatic medium‑term horizons.
Positioned as a multi‑asset fund manager in Poland, it emphasizes scalable retail and institutional distribution through its parent group while deploying a diversified, risk‑budgeted approach across fixed income, equities and balanced mandates. Capital allocation favors liability‑aware bond strategies, active equity selection and opportunistic credit within clearly defined liquidity and drawdown limits. Product strategy blends active and cost‑efficient passive solutions, prioritizes fee competitiveness, governance, centralized research and pragmatic medium‑term horizons.
| Trades 1495 | Longs Won 1044/1495 69% | Profit Factor 5.21 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $355,693.15 |
| Average Win $152,574.59 | Best Trade (Aug 28) $7.13M | Sharpe Ratio -9.77 |
| Average Loss -$67,817.9 | Worst Trade (Aug 13) -$1.6M | Z-Score 11.77 (100%) |
| Commissions $0 | Avg. Trade Length 1y 8m 3w 5d | Expectancy $86,088.3 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 4,016 | 3,614 | 3,213 | 2,811 | 2,410 | 2,008 | 1,606 | 1,205 | 803 | 402 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 17,400 | $3.06M | $5.38M | - | $2.32M | 75.81% | -7.354% |
ABBV AbbVie Inc. | 1,100 | $214,368.17 | $276,034 | - | $61,665.83 | 28.77% | -2.513% |
ABNB Airbnb, Inc. | 1,500 | $196,320 | $227,280 | - | $30,960 | 15.77% | -0.368% |
ACN Accenture plc Class A | 10,300 | $2.21M | $1.71M | - | -$496,835.77 | -22.52% | +1.611% |
ADBE Adobe Inc. | 19,149 | $8.15M | $4.8M | - | -$3.35M | -41.13% | +1.013% |
ADI Analog Devices, Inc. | 12,200 | $2.59M | $4.48M | - | $1.89M | 73.01% | +0.202% |
AIG American International Group Inc. | 11,700 | $835,658 | $919,386 | - | $83,728 | 10.02% | -0.393% |
ALGN Align Technology, Inc. | 600 | $111,982.32 | $101,496 | - | -$10,486.32 | -9.36% | -2.451% |
AMAT Applied Materials, Inc. | 5,700 | $874,460.94 | $2.89M | - | $2.02M | 230.91% | +1.176% |
AMD Advanced Micro Devices, Inc. | 12,500 | $1.54M | $5.95M | - | $4.42M | 287.5% | -1.904% |
AMGN Amgen Inc. | 2,500 | $618,511 | $962,900 | - | $344,389 | 55.68% | -0.64% |
AMZN Amazon.com Inc | 42,200 | $7.82M | $11.46M | - | $3.64M | 46.57% | +15.321% |
AVGO Broadcom Inc. | 5,300 | $1.76M | $2.06M | - | $302,034 | 17.15% | +0.371% |
AXP American Express Company | 4,300 | $855,046 | $1.45M | - | $590,829 | 69.1% | -0.376% |
BAC Bank of America Corporation | 48,000 | $1.75M | $2.97M | - | $1.23M | 70.13% | +0.356% |
BEAM Beam Therapeutics Inc. | 22,000 | $465,240 | $561,440 | - | $96,200 | 20.68% | -3.662% |
BILL Bill Holdings Inc. | 36,000 | $1.7M | $1.62M | - | -$76,435 | -4.49% | -0.573% |
BMY Bristol-Myers Squibb Company | 10,500 | $625,251 | $685,755 | - | $60,504 | 9.68% | +0.694% |
BNY BlackRock New York Municipal Income Trust | 1,600 | $72,704 | $250,128 | - | $177,424 | 244.04% | +0.16% |
BSX Boston Scientific Corporation | 85,000 | $4.6M | $3.97M | - | -$625,010 | -13.6% | +1.587% |